A bivalent inactivated influenza vaccine incorporating epitope-optimized surface proteins confers cross-protective immunity against H9N2 influenza virus. (tandfonline.com)

Authors: Hao M … Chen J Journal: Emerging Microbes & Infections Published: 2026-08-03 DOI: https://doi.org/10.1080/22221751.2026.2713325